This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: University of Michigan. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mohamed Dit Mady Traore: Innovator in Viral Infection Treatments
Introduction
Mohamed Dit Mady Traore is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. His innovative work has garnered attention for its potential impact on public health.
Latest Patents
Traore holds a patent for "Remdesivir and remdesivir analogs, solutions, and nanoparticle, liposomal, and microparticle compositions for treating viral infections." This invention focuses on methods, compounds, and compositions aimed at treating viral infections, including COVID-19. The patent outlines various embodiments of the compositions, which may include remdesivir analogs, surfactants, nanoparticles, liposomes, and microparticles. These compositions can be administered intravenously or inhaled as a dry powder.
Career Highlights
Traore is affiliated with the University of Michigan, where he conducts research and develops innovative solutions for viral infections. His work is characterized by a commitment to advancing medical science and improving treatment options for patients.
Collaborations
He has collaborated with notable colleagues, including Duxin Sun and Wei Gao, to further enhance the research and development of his inventions.
Conclusion
Mohamed Dit Mady Traore's contributions to the field of viral infection treatments exemplify the importance of innovation in medicine. His patent for remdesivir analogs represents a significant step forward in combating viral diseases, particularly in the context of the ongoing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
